Remove patients views-analysis
article thumbnail

Deep Dive: Patients and Partnerships 2022

pharmaphorum

The concept of patient centricity has been a key talking point across the healthcare ecosystem for years. Having recognised the tangible benefits that their unique insights and experiences can bring to the table, decision-makers are increasingly seeking new opportunities to partner with patients across a product’s lifecycle.

article thumbnail

True patient-focused research through decentralised and hybrid trials

pharmaphorum

How can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector give their thoughts on the key approaches and technologies that are driving patient engagement forward. The post True patient-focused research through decentralised and hybrid trials appeared first on.

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The efficacy of Mental Health Apps

pharmaphorum

In their meta-analysis of published studies, the authors found universal deficiencies and concluded that there’s no convincing evidence that app-based interventions deliver meaningful outcomes. I reviewed all 14 meta-analyses included in the study and found the analysis to be accurate, but incomplete. Consistent Standards Matter.

FDA 114
article thumbnail

Five Things To Know About Beta-Lactam Therapeutic Drug Monitoring (TDM)

IDStewardship

Beta-lactams such as piperacillin-tazobactam, cefepime, and meropenem form the backbone of antibiotic regimens in the sickest, most vulnerable hospitalized patients. Question 2: Which patients should have beta-lactam TDM performed? We will use a case to emphasize some points. Let us begin!

article thumbnail

The story behind the numbers: how burden of illness studies add value to HTA submissions

pharmaphorum

In a time of increasing cost pressures, limited resource capacity, and heightened demand for new treatments, Health Technology Assessments (HTAs) play a vital role in evaluating whether new interventions will provide sufficient patient benefits to justify the cost to the health service.

52
article thumbnail

Cytisine may offer viable alternative to varenicline for smoking cessation

Hospital Pharmacy Europe

With varenicline currently unavailable, it is possible that cytisine might serve as an alternative pharmacotherapy to help patients to stop smoking. Fortunately, one US company has recently completed several randomised trials on cytisine with a view to gaining FDA and, ultimately, UK and European approval.

article thumbnail

Deep Dive: Market Access

pharmaphorum

Turning words into actions with patient engagement. Boehringer Ingelheim’s Carinne Brouillon tells us how the company co-created its recent Global Patient Partnership Summit with patients. “A Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage.